transarterial radioembolization + CAPECITABINE + Temozolomide

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

transarterial radioembolization + CAPECITABINE + Temozolomide
Treatment and conditionWhere it standsTrials
transarterial radioembolization + CAPECITABINE + Temozolomide for neuroendocrine tumorsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1